Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Aolidan Bio-Technology Co., Ltd. (Aolidan) is a Chinese biotechnology firm specializing in the research, development, and industrial production of bioactive ingredients for the dermatology and personal care sectors. Founded in 2011, the company leverages core technologies in microbial fermentation, peptide synthesis, and natural plant extraction to develop high-performance raw materials. Aolidan's product portfolio is centered on bioactive peptides, such as Acetyl Hexapeptide-8 and Palmitoyl Pentapeptide-4, alongside specialized plant extracts designed for anti-aging, moisturizing, and skin-barrier repair. The company operates a sophisticated R&D center in Guangzhou and serves as a key strategic supplier of innovative biological components to major domestic and international cosmetic brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aolidanide.